$78.91
+0.44 (+0.56%)
Performance
1D
+0.00%
1W
+0.37%
1M
+29.85%
3M
+0.80%
6M
+13.98%
1Y
-5.89%
YTD
-0.23%
Open$78.65
Previous Close$78.47
Day High$79.52
Day Low$77.67
52W High$99.50
52W Low$40.00
Volume—
Avg Volume1.16M
Market Cap3.50B
P/E Ratio—
EPS$-6.57
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$71.21
Above
SMA 200
$70.84
Above
RSI (14)
50
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
-71.5% upside
Current
$78.91
$78.91
Target
$22.47
$22.47
$15.33
$22.47 avg
$35.88
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.46B | 1.47B | 1.18B |
| Net Income | -261,677,643 | -297,076,371 | -250,070,353 |
| Profit Margin | -18.0% | -20.2% | -21.1% |
| EBITDA | -537,620,569 | -578,764,523 | -403,482,661 |
| Free Cash Flow | -321,004,356 | -279,609,663 | -183,137,834 |
| Rev Growth | +12.9% | +6.2% | -8.5% |
| Debt/Equity | 0.11 | 0.12 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |